Minerva Neurosciences, Inc

NERV

$6.33

Name : Minerva Neurosciences, Inc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $273,926,944.00

EPSttm : -1.85

Minerva Neurosciences, Inc

$6.33

0.32%

$0.02

Float Short %

1.07

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.22

EPS Last/This Y

-1.59

EPS This/Next Y

0.86

Price

6.32

Target Price

4.5

Analyst Recom

Performance Q

66.14

Relative Volume

1.54

Beta

-0.28

Ticker: NERV

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-13	NERV	4.27	N/A	N/A	0
2026-01-14	NERV	4.38	N/A	N/A	0
2026-01-15	NERV	4.43	N/A	N/A	0
2026-01-16	NERV	4.5	N/A	N/A	0
2026-01-20	NERV	4.43	N/A	N/A	0
2026-01-21	NERV	4.21	N/A	N/A	0
2026-01-22	NERV	3.98	N/A	N/A	0
2026-01-23	NERV	3.99	N/A	N/A	0
2026-01-26	NERV	4.13	N/A	N/A	0
2026-01-27	NERV	4.39	N/A	N/A	0
2026-01-28	NERV	4.18	N/A	N/A	0
2026-01-29	NERV	4.25	N/A	N/A	0
2026-01-30	NERV	4.07	N/A	N/A	0
2026-02-02	NERV	4.68	N/A	N/A	0
2026-02-03	NERV	4.98	N/A	N/A	0
2026-02-04	NERV	4.64	N/A	N/A	0
2026-02-05	NERV	4.28	N/A	N/A	0
2026-02-06	NERV	4.81	N/A	N/A	0
2026-02-09	NERV	5.68	N/A	N/A	0
2026-02-10	NERV	6.27	N/A	N/A	0
2026-02-11	NERV	6.31	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-13	NERV	4.28	80.4	-	-1.40
2026-01-14	NERV	4.31	80.4	-	-1.40
2026-01-15	NERV	4.39	80.4	-	-1.40
2026-01-16	NERV	4.50	80.4	-	-1.40
2026-01-20	NERV	4.35	80.4	-	-1.40
2026-01-21	NERV	4.19	80.4	-	-1.40
2026-01-22	NERV	3.90	80.4	-	-1.40
2026-01-23	NERV	4.00	80.4	-	-1.40
2026-01-26	NERV	4.07	80.4	-	-1.40
2026-01-27	NERV	4.36	80.4	-	-1.40
2026-01-28	NERV	4.17	80.4	-	-1.40
2026-01-29	NERV	4.24	80.4	-	-1.40
2026-01-30	NERV	4.04	80.4	-	-1.40
2026-02-02	NERV	4.67	80.4	-	-1.40
2026-02-03	NERV	4.95	80.4	-	-1.40
2026-02-04	NERV	4.61	80.4	-	-1.40
2026-02-05	NERV	4.26	80.4	-	-1.40
2026-02-06	NERV	4.84	80.4	-	-1.40
2026-02-09	NERV	5.69	80.4	-	-1.40
2026-02-10	NERV	6.29	80.4	-	-1.40
2026-02-11	NERV	6.32	80.4	-	-1.40
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-13	NERV	0.00	8.08	3.55
2026-01-14	NERV	0.00	8.08	3.55
2026-01-15	NERV	0.00	8.08	0.88
2026-01-16	NERV	0.00	8.08	0.88
2026-01-20	NERV	0.00	8.08	0.88
2026-01-21	NERV	0.00	8.08	0.88
2026-01-22	NERV	0.00	8.08	0.88
2026-01-23	NERV	0.00	8.08	0.88
2026-01-26	NERV	0.00	8.06	0.88
2026-01-27	NERV	0.00	8.06	0.88
2026-01-28	NERV	0.00	8.06	0.85
2026-01-29	NERV	0.00	8.06	0.85
2026-01-30	NERV	0.00	8.06	0.85
2026-02-02	NERV	0.00	8.06	0.85
2026-02-03	NERV	0.00	8.06	0.85
2026-02-04	NERV	0.00	8.06	0.85
2026-02-05	NERV	0.00	8.06	0.85
2026-02-06	NERV	0.00	8.06	0.85
2026-02-09	NERV	0.00	23.69	0.85
2026-02-10	NERV	0.00	23.69	0.85
2026-02-11	NERV	0.00	23.69	1.07
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.11

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

Institutional Transactions

23.69

Beta

-0.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.6

Max Drawdown 5-Year %

-95.3

Target Price

4.5

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-1.85

Average EPS Est. Cur. Y

-1.4

EPS Next Y. (Est.)

-0.54

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.54

Return on Equity vs Sector %

12.7

Return on Equity vs Industry %

29.1

EPS 1 7Days Diff

-1.4

EPS 1 30Days Diff

-1.4

EBIT Estimation

Minerva Neurosciences, Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 8

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

stock quote shares NERV – Minerva Neurosciences, Inc. Stock Price stock today

news today NERV – Minerva Neurosciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NERV – Minerva Neurosciences, Inc. yahoo finance google finance

stock history NERV – Minerva Neurosciences, Inc. invest stock market

stock prices NERV premarket after hours

ticker NERV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NERV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y